Takeda Pharmaceutical Company Limited
TKPHF
$26.44
-$1.28-4.63%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -109.30% | 227.09% | -533.93% | -74.81% | 1.34% |
| Total Depreciation and Amortization | -0.26% | 28.32% | -20.06% | -5.32% | 4.99% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 415.98% | -145.14% | 57.58% | 22.06% | 290.83% |
| Change in Net Operating Assets | 163.75% | -1,337.72% | -96.76% | 222.17% | 7.40% |
| Cash from Operations | 71.95% | 2.32% | -42.07% | 33.12% | 73.01% |
| Capital Expenditure | 18.04% | -3.61% | -8.29% | 11.18% | 9.68% |
| Sale of Property, Plant, and Equipment | -100.00% | 20,951.43% | 300.00% | -73.09% | 238.13% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -98.82% | 181.84% | 770.93% | -77.21% | 92.16% |
| Other Investing Activities | 60.78% | -222.07% | 125.27% | -124.98% | 68.11% |
| Cash from Investing | -42.02% | -77.96% | 82.96% | -49.90% | 49.72% |
| Total Debt Issued | 86.60% | 567.72% | -31.28% | -91.61% | -6.07% |
| Total Debt Repaid | -66.70% | 20.55% | 54.79% | 6.50% | -600.25% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 100.00% | -3.25% | -- | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 94.08% | -1,474.33% | 93.30% | -1,441.03% | 93.02% |
| Other Financing Activities | -120.53% | 53.27% | 2.69% | -26.65% | -216.96% |
| Cash from Financing | 94.54% | 24.86% | 53.96% | -480.96% | -136.48% |
| Foreign Exchange rate Adjustments | 637.51% | 73.51% | -142.43% | 153.37% | -354.46% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,024.77% | 66.02% | 70.10% | -758.53% | -83.69% |